A Round Table Discussion featuring perspectives and insights from three thought leaders on: Reassessing the Paradigm in RCC to Meet the Challenges and Leverage the Advantages of Combination Therapy • analyzing how new approaches to combination therapy can address multiple pathways in kidney cancer • ‘take-home’ messages on how these strategies can optimize progression-free survival Plus: • How targeted therapies are being applied in VHL Disease • Highlights from the 2017 Kidney Cancer Association Scientific Sessions in Miami, November 3-4.
30114GA
To see the actual publication please follow the link above